115 related articles for article (PubMed ID: 34225617)
1. Variances in the Expression Profile of the EMT-Related Genes in Endometrial Cancer Lines In Vitro Study.
Nowakowski R; Grabarek B; Burnat-Olech A; Boroń D; Paul-Samojedny M
Curr Pharm Biotechnol; 2022; 23(4):594-608. PubMed ID: 34225617
[TBL] [Abstract][Full Text] [Related]
2. Molecular Landscape of the Epithelial-Mesenchymal Transition in Endometrioid Endometrial Cancer.
Opławski M; Nowakowski R; Średnicka A; Ochnik D; Grabarek BO; Boroń D
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917330
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Differences in the Expression of mRNAs and miRNAs Associated with Drug Resistance in Endometrial Cancer Cells Treated with Salinomycin.
Januszyk P; Januszyk K; Wierzbik-Strońska M; Boroń D; Grabarek B
Curr Pharm Biotechnol; 2021; 22(4):541-548. PubMed ID: 32598254
[TBL] [Abstract][Full Text] [Related]
4. Expression Profile of EMT-related Genes and miRNAs Involved in Signal Transduction via the Wnt Pathway and Cadherins in Endometrial Cancer.
Zmarzły N; Hermyt E; Kruszniewska-Rajs C; Gola J; Witek A; Mazurek U; Ostenda A; Boroń D
Curr Pharm Biotechnol; 2021; 22(12):1663-1671. PubMed ID: 33342410
[TBL] [Abstract][Full Text] [Related]
5. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.
Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R
J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127
[TBL] [Abstract][Full Text] [Related]
6. Salinomycin Modulates the Expression of mRNAs and miRNAs Related to Stemness in Endometrial Cancer.
Talkowski K; Kiełbasiński K; Peszek W; Grabarek BO; Boroń D; Oplawski M
Curr Pharm Biotechnol; 2021; 22(2):317-326. PubMed ID: 32564748
[TBL] [Abstract][Full Text] [Related]
7. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P
Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
[TBL] [Abstract][Full Text] [Related]
11. The Influence of Salinomycin on the Expression Profile of mRNAs Encoding Selected Caspases and MiRNAs Regulating their Expression in Endometrial Cancer Cell Line.
Januszyk K; Januszyk P; Grabarek BO; Boroñ D; Oplawski M
Curr Pharm Biotechnol; 2020; 21(14):1505-1515. PubMed ID: 32407273
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.
Dong P; Kaneuchi M; Watari H; Hamada J; Sudo S; Ju J; Sakuragi N
Mol Cancer; 2011 Aug; 10():99. PubMed ID: 21851624
[TBL] [Abstract][Full Text] [Related]
13. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
[TBL] [Abstract][Full Text] [Related]
14. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J
J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1.
Xiong H; Chen R; Liu S; Lin Q; Chen H; Jiang Q
J Cell Biochem; 2018 Nov; 119(10):8123-8137. PubMed ID: 29923214
[TBL] [Abstract][Full Text] [Related]
16. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑21‑5p promotes epithelial to mesenchymal transition by targeting SRY‑box 17 in endometrial cancer.
Wang C; Li Q; He Y
Oncol Rep; 2020 Jun; 43(6):1897-1905. PubMed ID: 32236579
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines.
Bai JX; Yan B; Zhao ZN; Xiao X; Qin WW; Zhang R; Jia LT; Meng YL; Jin BQ; Fan DM; Wang T; Yang AG
Endocrinology; 2013 Feb; 154(2):635-45. PubMed ID: 23295740
[TBL] [Abstract][Full Text] [Related]
19. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1.
Liu W; Zhang B; Xu N; Wang MJ; Liu Q
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3787-3793. PubMed ID: 28975990
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Impact of Cisplatin on Variances in the Expression Pattern of Leptin-Related Genes in Endometrial Cancer Cells.
Dąbruś D; Kiełbasiński R; Grabarek BO; Boroń D
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
